Insider · CIK 0001207107
David R Ebsworth
director
Files at VRNA (Verona Pharma plc). First filing Nov 7, 2024, latest Aug 5, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 1
$278k bought, $25k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | Verona Pharma plc | $25k 1,904 shares | -0% | - | |
| 37Weak | Verona Pharma plc | $89k 20,000 shares | +2% | - | |
| 35Weak | Verona Pharma plc | $189k 39,360 shares | +4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | VRNA Verona Pharma plc | DDisposition to issuer Ordinary Shares | -880,499 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares | +72,000 | - | - | 72,000 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | DDisposition to issuer Ordinary Shares | -72,000 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | DDisposition to issuer Ordinary Sharesindirect: By Ebsworth GmbH | -617,600 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitderivative | -72,000 | - | - | 0 | Oct 8, 2025 |
| Aug 1, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares | +24,000 | $0.00 | $0 | 882,403 | Aug 5, 2025 |
| Aug 1, 2025 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares | -1,904 | $13.14 | $25k | 880,499 | Aug 5, 2025 |
| Aug 1, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Stock Unitsderivative | -24,000 | $0.00 | $0 | 72,000 | Aug 5, 2025 |
| May 1, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares | +140,000 | $1.93 | $271k | 1,476,003 | May 5, 2025 |
| May 1, 2025 | VRNA Verona Pharma plc | MOption exercise Stock Option (Right to Exercise)derivative | +140,000 | $0.00 | $0 | 0 | May 5, 2025 |
| Apr 25, 2025 | VRNA Verona Pharma plc | AGrant or award Restricted Share Unitsderivative | +96,000 | $0.00 | $0 | 96,000 | Apr 29, 2025 |
| Feb 26, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares | +64,000 | $0.78 | $50k | 1,004,003 | Feb 28, 2025 |
| Feb 26, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares | +200,000 | $0.50 | $101k | 1,204,003 | Feb 28, 2025 |
| Feb 26, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares | +96,000 | $2.67 | $256k | 1,300,003 | Feb 28, 2025 |
| Feb 26, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares | +100,000 | $1.93 | $193k | 1,400,003 | Feb 28, 2025 |
| Feb 26, 2025 | VRNA Verona Pharma plc | GGift Ordinary Shares | -64,000 | $0.00 | $0 | 1,336,003 | Feb 28, 2025 |
| Feb 26, 2025 | VRNA Verona Pharma plc | MOption exercise Share Option (Right to Exercise)derivative | -64,000 | $0.00 | $0 | 0 | Feb 28, 2025 |
| Feb 26, 2025 | VRNA Verona Pharma plc | MOption exercise Share Option (Right to Exercise)derivative | -200,000 | $0.00 | $0 | 0 | Feb 28, 2025 |
| Feb 26, 2025 | VRNA Verona Pharma plc | MOption exercise Share Option (Right to Exercise)derivative | -96,000 | $0.00 | $0 | 0 | Feb 28, 2025 |
| Feb 26, 2025 | VRNA Verona Pharma plc | MOption exercise Share Option (Right to Exercise)derivative | -100,000 | $0.00 | $0 | 140,000 | Feb 28, 2025 |
| Nov 18, 2024 | VRNA Verona Pharma plc | POpen-market purchase Ordinary Shares | +20,000 | $4.44 | $89k | 940,003 | Nov 18, 2024 |
| Nov 6, 2024 | VRNA Verona Pharma plc | POpen-market purchase Ordinary Shares | +39,360 | $4.80 | $189k | 920,003 | Nov 7, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.